FDA panel backs Pfizer vaccine for adults - BusinessWeek

[INCIID News Feed]

Washington Times
<img alt="" height="1" width="1" />
FDA panel backs Pfizer vaccine for adults
BusinessWeek
A panel of federal health experts voted overwhelmingly Wednesday to recommend that Pfizer&#39;s best-selling vaccine be approved for a new use in preventing pneumococcal disease in adults age 50 and older. The Food and Drug Administration&#39;s vaccine panel ...
FDA panel backs Pfizer vaccine for adultsReuters
FDA Panel Votes to Expand Use of Pneumococcal Vaccine to AdultsMedPage Today
FDA Panel: Expand Approval of Pneumococcal VaccineFamily Practice News Digital Network
Medscape -FierceVaccines -CBS News
all 43 news articles &raquo;


More...